{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:17:12Z","timestamp":1791685032680,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["15ZR1405900"],"award-info":[{"award-number":["15ZR1405900"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["19ZR1408300"],"award-info":[{"award-number":["19ZR1408300"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["17410712500"],"award-info":[{"award-number":["17410712500"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["201906100167"],"award-info":[{"award-number":["201906100167"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013098","name":"Scientific and Innovative Action Plan of Shanghai","doi-asserted-by":"publisher","award":["19441900600"],"award-info":[{"award-number":["19441900600"]}],"id":[{"id":"10.13039\/501100013098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Science and Engineering: C"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.msec.2021.112274","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T03:24:24Z","timestamp":1624677864000},"page":"112274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Inhibiting corneal neovascularization by sustainably releasing anti-VEGF and anti-inflammation drugs from silica-thermogel nanohybrids"],"prefix":"10.1016","volume":"128","author":[{"given":"Ning","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghuai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msec.2021.112274_bb0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00109-013-0993-5","article-title":"Ocular neovascularization","volume":"91","author":"Campochiaro","year":"2013","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.msec.2021.112274_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108363","article-title":"Corneal neovascularization","volume":"202","author":"Nicholas","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.msec.2021.112274_bb0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","article-title":"Current and emerging therapies for corneal neovascularization","volume":"16","author":"Roshandel","year":"2018","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.msec.2021.112274_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1755-3768.2011.02312.x","article-title":"The association between corneal neovascularization and visual acuity: a systematic review","volume":"91","author":"Bachmann","year":"2013","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.msec.2021.112274_bb0025","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2217\/rme-2016-0054","article-title":"Advances in corneal cell therapy","volume":"11","author":"Fuest","year":"2016","journal-title":"Regen. Med."},{"key":"10.1016\/j.msec.2021.112274_bb0030","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.msec.2021.112274_bb0035","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular endothelial growth factor a in intraocular vascular disease","volume":"120","author":"Miller","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.msec.2021.112274_bb0040","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jconrel.2020.01.036","article-title":"Injectable biodegradable bi-layered capsule for sustained delivery of bevacizumab in treating wet age-related macular degeneration","volume":"320","author":"Jiang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2021.112274_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111398","article-title":"Novel hybrid lipid nanocapsules loaded with a therapeutic monoclonal antibody - bevacizumab - and triamcinolone acetonide for combined therapy in neovascular ocular pathologies","volume":"119","author":"Formica","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.msec.2021.112274_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/08820538.2011.588652","article-title":"Inflammatory corneal neovascularization: etiopathogenesis","volume":"26","author":"Clements","year":"2011","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.msec.2021.112274_bb0055","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1167\/iovs.10-5455","article-title":"Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesis","volume":"51","author":"Liclican","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.msec.2021.112274_bb0060","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1007\/s00417-013-2467-4","article-title":"Inhibitory effects of topical cyclosporine A 0.05% on immune-mediated corneal neovascularization in rabbits","volume":"251","author":"Bucak","year":"2013","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.msec.2021.112274_bb0065","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1007\/s12274-019-2546-x","article-title":"A novel chitosan nanocapsule for enhanced skin penetration of cyclosporin A and effective hair growth in vivo","volume":"12","author":"Lee","year":"2019","journal-title":"Nano Res."},{"key":"10.1016\/j.msec.2021.112274_bb0070","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1021\/acsami.0c21710","article-title":"Reduction-responsive chemo-capsule-based prodrug nanogel for synergistic treatment of tumor chemotherapy","volume":"13","author":"Lu","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.msec.2021.112274_bb0075","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.msec.2019.02.081","article-title":"A polysaccharide-based micelle-hydrogel synergistic therapy system for diabetes and vascular diabetes complications treatment","volume":"100","author":"Wen","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.msec.2021.112274_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201907035","article-title":"Nanoarchitectured structure and surface biofunctionality of mesoporous silica nanoparticles","volume":"32","author":"Kankala","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.msec.2021.112274_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201902634","article-title":"Mesoporous silica nanoparticles for drug delivery","volume":"30","author":"Manzano","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.msec.2021.112274_bb0090","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/adma.201104763","article-title":"Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery","volume":"24","author":"Tang","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.msec.2021.112274_bb0095","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/nl404316v","article-title":"Biphase stratification approach to three-dimensional dendritic biodegradable mesoporous silica nanospheres","volume":"14","author":"Shen","year":"2014","journal-title":"Nano Lett."},{"key":"10.1016\/j.msec.2021.112274_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801047","article-title":"Local delivery and sustained-release of nitric oxide donor loaded in mesoporous silica particles for efficient treatment of primary open-angle glaucoma","volume":"7","author":"Hu","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.msec.2021.112274_bb0105","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2147\/IJN.S195504","article-title":"Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy","volume":"14","author":"Sun","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.msec.2021.112274_bb0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2020.11.049","article-title":"Injectable thermoresponsive hydrogels as drug delivery system for the treatment of central nervous system disorders: a review","volume":"329","author":"Bellotti","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.msec.2021.112274_bb0115","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1021\/acsami.6b16509","article-title":"Sustained release of brimonidine from a new composite drug delivery system for treatment of glaucoma","volume":"9","author":"Sun","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.msec.2021.112274_bb0120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijpharm.2015.05.071","article-title":"An injectable thermosensitive polymeric hydrogel for sustained release of Avastin\u00ae to treat posterior segment disease","volume":"490","author":"Xie","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.msec.2021.112274_bb0125","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1167\/iovs.16-20899","article-title":"Development of a sustained-release voriconazole containing thermogel for subconjunctival injection in horses","volume":"58","author":"Cuming","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.msec.2021.112274_bb0130","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1039\/C7TB01556A","article-title":"Sustained subconjunctival delivery of cyclosporine A using thermogelling polymers for glaucoma filtration surgery","volume":"5","author":"Sun","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.msec.2021.112274_bb0135","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1755-3768.2008.01399.x","article-title":"Therapeutic effect of subconjunctival injection of bevacizumab in the treatment of corneal neovascularization","volume":"87","author":"You","year":"2009","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.msec.2021.112274_bb0140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1080\/02713683.2017.1416146","article-title":"Corneal neovascularization: a combined approach of bevacizumab and suramin showed increased antiangiogenic effect through downregulation of BFGF and P2X2","volume":"43","author":"Lopez","year":"2018","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.msec.2021.112274_bb0145","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/452685","article-title":"Inhibition of corneal neovascularization by topical and subconjunctival tigecycline","volume":"2014","author":"Goktas","year":"2014","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.msec.2021.112274_bb0150","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1002\/smll.201401538","article-title":"Synthesis of silica vesicles with controlled entrance size for high loading, sustained release, and cellular delivery of therapeutical proteins","volume":"10","author":"Zhang","year":"2014","journal-title":"Small"},{"key":"10.1016\/j.msec.2021.112274_bb0155","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1016\/j.bbapap.2013.07.015","article-title":"Recent applications of ATR FTIR spectroscopy and imaging to proteins","volume":"1834","author":"Glassford","year":"2013","journal-title":"Biochim. Biophys. Acta Protein Proteomics"},{"key":"10.1016\/j.msec.2021.112274_bb0160","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1039\/C4BM00029C","article-title":"Comparative studies of thermogels in preventing post-operative adhesions and corresponding mechanisms","volume":"2","author":"Yu","year":"2014","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.msec.2021.112274_bb0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-6750-14-17","article-title":"Pharmacological characteristics and efficacy of a novel anti-angiogenic antibody FD006 in corneal neovascularization","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.msec.2021.112274_bb0170","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.301.2.738","article-title":"Anti-inflammatory effects of a cyclosporine receptor-binding compound, D-43787","volume":"301","author":"Pahl","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.msec.2021.112274_bb0175","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1159\/000350614","article-title":"Cyclosporine attenuates arginine transport, in human endothelial cells, through modulation of cationic amino acid transporter-1","volume":"37","author":"Grupper","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.msec.2021.112274_bb0180","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3390\/nano10040815","article-title":"Enhancing the cellular uptake and antibacterial activity of rifampicin through encapsulation in mesoporous silica nanoparticles","volume":"10","author":"Joyce","year":"2020","journal-title":"Nanomaterials-Basel"},{"key":"10.1016\/j.msec.2021.112274_bb0185","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1517\/17425247.2014.924503","article-title":"Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy","volume":"11","author":"Zhang","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.msec.2021.112274_bb0190","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1021\/acsami.6b12524","article-title":"Mesoporous silica nanoparticles as an antitumoral-angiogenesis strategy","volume":"9","author":"Setyawati","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.msec.2021.112274_bb0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/jop.2009.0022","article-title":"Aqueous humor concentration of bevacizumab after subconjunctival injection in rabbit","volume":"26","author":"Kim","year":"2010","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.msec.2021.112274_bb0200","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/jop.2018.0106","article-title":"Ocular distribution of cyclosporine following topical administration of OTX-101 in New Zealand white rabbits","volume":"35","author":"Weiss","year":"2019","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.msec.2021.112274_bb0205","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","article-title":"Nanocarriers for ocular drug delivery: current status and translational opportunity","volume":"10","author":"Gorantla","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.msec.2021.112274_bb0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.advms.2015.10.003","article-title":"Assessment of therapeutic options for reducing alkali burn-induced corneal neovascularization and inflammation","volume":"61","author":"Bakunowicz-\u0141azarczyk","year":"2016","journal-title":"Adv. Med. Sci."}],"container-title":["Materials Science and Engineering: C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493121004136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928493121004136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T13:23:20Z","timestamp":1760534600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928493121004136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":42,"alternative-id":["S0928493121004136"],"URL":"https:\/\/doi.org\/10.1016\/j.msec.2021.112274","relation":{},"ISSN":["0928-4931"],"issn-type":[{"value":"0928-4931","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibiting corneal neovascularization by sustainably releasing anti-VEGF and anti-inflammation drugs from silica-thermogel nanohybrids","name":"articletitle","label":"Article Title"},{"value":"Materials Science and Engineering: C","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msec.2021.112274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"112274"}}